Výsledky vyhledávání - "Kenneth, Lieberman"

Practice patterns and outcomes of repository corticotropin injection (Acthar® Gel) use in childhood nephrotic syndrome: A study of the North American Pediatric Renal Trials and collaborative studies and the Pediatric Nephrology Research Consortium

Autor: Mark R. Benfield, Traci Leong, Courtney McCracken, Kenneth Lieberman, Mohammed K Faizan

Publikováno v: Journal of Clinical Nephrology. 5:067-076

Objective: We set up a U.S. registry to examine prescription patterns and patient outcomes of repository corticotropin injection (Acthar® Gel) for childhood nephrotic syndrome. Methods: 18 participating U.S. pediatric centers performed retrospective

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fe182f676b6986b80b0a82ac824af85b
https://doi.org/10.29328/journal.jcn.1001077

Zobrazit plný text záznamu

FC 023SAFETY OF BARDOXOLONE METHYL IN PEDIATRIC PATIENTS WITH ALPORT SYNDROME IN CARDINAL PHASE 3 TRIAL

Autor: Kenneth Lieberman, Clifford E. Kashtan, Vimal Chadha, Angie Goldsberry, Bradley A. Warady, Keisha L. Gibson, Rasheed A Gbadagesin, Kevin E.C. Meyers, Kandai Nozu, Debbie S. Gipson, Colin J. Meyer, Melanie Chin, Megan O'Grady, Michelle N. Rheault

Publikováno v: Nephrology Dialysis Transplantation. 36

Background and Aims Alport syndrome is a genetic disease accounting for an estimated 3% of children with end-stage kidney disease (ESKD) in the US (USRDS, 2014). Current management recommendations include the use of renin-angiotensin-aldosterone syst

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::208538010f2fbd87b348c11b97990352
https://doi.org/10.1093/ndt/gfab133.003

Zobrazit plný text záznamu

Loss-of-Function Mutations in YY1AP1 Lead to Grange Syndrome and a Fibromuscular Dysplasia-Like Vascular Disease

Publikováno v: American Journal of Human Genetics, 100, 21-30
American Journal of Human Genetics, 100, 1, pp. 21-30

Contains fulltext : 169736.pdf (Publisher’s version ) (Closed access) Fibromuscular dysplasia (FMD) is a heterogeneous group of non-atherosclerotic and non-inflammatory arterial diseases that primarily involves the renal and cerebrovascular arterie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e360a5dd25aea135da58506d41d812e7
https://doi.org/10.1016/j.ajhg.2016.11.008

Zobrazit plný text záznamu

Clinical trial recommendations for potential Alport syndrome therapies

Autor: B. André Weinstock, David L. Feldman, Alessia Fornoni, Oliver Gross, Clifford E. Kashtan, Sharon Lagas, Rachel Lennon, Jeffrey H. Miner, Michelle N. Rheault, James F. Simon, Lisa Bonebrake, Marty Dunleavy, Phil Kumnick, Gina Parziale, Janine Reed, André Weinstock, Susie Gear, Kristen Binaso, Raymond Manuel, James Simon, Gerald Appel, Melanie Blank, Winson Tang, Aliza Thompson, Roser Torra, Kenneth Lieberman, Christoph Licht, Karin Dahan, Kandai Nozu, Hirofumi Kai, Sharon Ricardo, Anne Pariser, David Feldman, Heather Cook, Melanie Chin, Angela Goldsberry, Colin Meyer, Lisa Anne Melia, Radko Komers, Michael Markels, Alex Mercer, Marco Prunotto, Bruce Morgenstern, Ali Hariri, Vijay Modur, Neil Turner, Clifford Kashtan, Michelle Rheault, Colin Baigent, Stephano DeSacco, Laura Perin, Moumita Barua, Koichi Nakanishi, George Jarad, Jeffrey Miner

Publikováno v: Weinstock, B A, Feldman, D L, Fornoni, A, Gross, O, Kashtan, C E, Lagas, S, Lennon, R, Miner, J H, Rheault, M N, Simon, J F, Bonebrake, L, Dunleavy, M, Kumnick, P, Lagas, S, Parziale, G, Reed, J, Weinstock, A, Gear, S, Binaso, K, Manuel, R, Simon, J, Appel, G, Blank, M, Tang, W, Thompson, A, Torra, R, Lieberman, K, Licht, C, Dahan, K, Nozu, K, Kai, H, Ricardo, S, Pariser, A, Feldman, D, Cook, H, Chin, M, Goldsberry, A, Meyer, C, Melia, L A, Komers, R, Markels, M, Mercer, A, Prunotto, M, Morgenstern, B, Hariri, A, Modur, V, Turner, N, Gross, O, Fornoni, A, Kashtan, C, Rheault, M, Baigent, C, Desacco, S, Perin, L, Barua, M, Nakanishi, K, Jarad, G & Miner, J 2020, ' Clinical trial recommendations for potential Alport syndrome therapies ', Kidney International, vol. 97, no. 6, pp. 1109-1116 . https://doi.org/10.1016/j.kint.2020.02.029

Alport syndrome is experiencing a remarkable increase in preclinical investigations. To proactively address the needs of the Alport syndrome community, as well as offer clarity for future clinical research sponsors, the Alport Syndrome Foundation hos

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7cd31a3ba1cfa1d09aa0e0800dd0db1
https://pubmed.ncbi.nlm.nih.gov/32386680

Zobrazit plný text záznamu

Adrenocorticotropic hormone therapy for the treatment of idiopathic nephrotic syndrome in children and young adults: a systematic review of early clinical studies with contemporary relevance

Autor: Anna Pavlova-Wolf, Kenneth Lieberman

Publikováno v: Journal of Nephrology

Adrenocorticotropic hormone (ACTH) as a treatment for proteinuria due to nephrotic syndrome (NS) has re-emerged over the last decade. Current clinical data are primarily limited to adults with treatment-resistant NS. Largely unknown to today’s clin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa55fb9822fc5dc372b4b0a9f82d5c77
http://europepmc.org/articles/PMC5316399

Zobrazit plný text záznamu

DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS

Publikováno v: Journal of the American Society of Nephrology : JASN. 29(11)

Background We evaluated and compared the effects of sparsentan, a dual endothelin type A (ET A ) and angiotensin II type 1 receptor antagonist, with those of the angiotensin II type 1 receptor antagonist irbesartan in patients with primary FSGS. Meth

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2ad5013ec52230ce891e0144ab26db0
https://pubmed.ncbi.nlm.nih.gov/30361325

Zobrazit plný text záznamu

Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome

Autor: Christoph Licht, Silvio Maringhini, Gianluigi Ardissino, Johan Vande Walle, Camille L. Bedrosian, Jonathan R. Evans, Larry A. Greenbaum, Paul Henning, Lars Pape, Nicole C. A. J. van de Kar, Samhar I. Al-Akash, Marc Fila, Masayo Ogawa, Lesley Rees, Kenneth Lieberman

Publikováno v: KIDNEY INTERNATIONAL
Kidney International. Supplement, 89, 3, pp. 701-11
Kidney International. Supplement, 89, 701-11

Contains fulltext : 172400.pdf (Publisher’s version ) (Open Access) Atypical hemolytic uremic syndrome (aHUS) is caused by alternative complement pathway dysregulation, leading to systemic thrombotic microangiopathy (TMA) and severe end-organ damag

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a6b40df4b5641118b1da1deb7306ad0
https://biblio.ugent.be/publication/7086892

Zobrazit plný text záznamu

The Efficacy and Safety of Valsartan in Obese and Non-Obese Pediatric Hypertensive Patients

Autor: Susan Solar-Yohay, Victor Shi, Guangyang Han, Kenneth Lieberman, Kevin E.C. Meyers

Publikováno v: The Journal of Clinical Hypertension. 13:758-766

J Clin Hypertens (Greenwich). 2011;13:758–766. ©2011 Wiley Periodicals, Inc. This post hoc analysis assessed the efficacy and tolerability of valsartan for the treatment of hypertension in obese vs non-obese children and adolescents. After a 1-wee

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9e04313eb867794e1537cfaf4f58791c
https://doi.org/10.1111/j.1751-7176.2011.00502.x

Zobrazit plný text záznamu

A new case of Grange syndrome without cardiac findings

Autor: Donna Wallerstein, Kenneth Lieberman, Robert Wallerstein, Valerie L. Johnson, Ann Marie Augustyn, Leslie Elton, Beatriz Tejeiro

Publikováno v: American Journal of Medical Genetics Part A. :1316-1320

Grange syndrome comprises arterial stenoses with hypertension, brachysyndactyly, bone fragility, learning disability, and cardiac defects. To date, we know of two reported families with five affected individuals. We report on one of the youngest case

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::792dabad8468e05b0b27e9889a5c5b89
https://doi.org/10.1002/ajmg.a.31125

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání